![Bo Angelin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bo Angelin
Corporate Officer/Principal en Karolinska Institutet .
Perfil
Bo Angelin is currently a Professor at Karolinska Institutet and the Head of the Endocrinology & Metabolism Department at Karolinska University Hospital.
He previously worked as a Non-Executive Director at AstraZeneca PLC.
Cargos activos de Bo Angelin
Empresas | Cargo | Inicio |
---|---|---|
Karolinska Institutet | Corporate Officer/Principal | 06/01/2011 |
Karolinska University Hospital
![]() Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Corporate Officer/Principal | 06/01/2011 |
Antiguos cargos conocidos de Bo Angelin.
Empresas | Cargo | Fin |
---|---|---|
ASTRAZENECA PLC | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Karolinska University Hospital
![]() Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Health Services |
- Bolsa de valores
- Insiders
- Bo Angelin